600521 华海药业
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额195,1082,172,6642,217,0211,242,693938,430
投资活动产生之现金流量净额(432,159)(1,920,276)(1,622,771)(2,432,575)(2,356,859)
筹资活动产生之现金流量净额955,629(132,912)(644,232)609,0431,118,346
汇率变动对现金及现金等价物的影响5,14951,15828,99854,654(43,491)
现金及现金等价物净增加/(减少)723,727170,634(20,984)(526,185)(343,574)
期初现金及现金等价物余额1,477,6001,306,9661,327,9501,854,1352,197,709
期末现金及现金等价物余额2,201,3271,477,6001,306,9661,327,9501,854,135